Yanbin Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yanbin Zhu has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- Yingze Zhang
Nankai University, Tianjin, China
18 shared publications - Wei Chen
Trauma Emergency Center, the Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China
9 shared publications Chengsi Li
Department of Orthopedic Surgery, the 3rd Hospital of Hebei Medical University
7 shared publicationsChunxu Fu
Department of Orthopaedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, China
5 shared publicationsDongwei Wu
Department of Orthopedic Surgery, the 3rd Hospital of Hebei Medical University
5 shared publicationsXin Xing
Department of Orthopaedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, China
5 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in Journal of Nanobiotechnology
Mechano-programmed osteocyte-derived small extracellular vesicles for exercise-inspired osteoporosis therapy
- 29 September 2026
- Published by Springer Nature in Journal of Nanobiotechnology
Open AccessMechano-programmed osteocyte-derived small extracellular vesicles for exercise-inspired osteoporosis therapy
- Open Access
- 2 September 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
Association between the preoperative geriatric nutritional risk index and loss of walking independence 180 days after hip fracture surgery: A retrospective cohort study
Background: Malnutrition may impair recovery after hip fracture, but the association between preoperative geriatric nutritional risk index (GNRI) and postoperative walking outcomes remains unclear. We examined the association between GNRI and loss of walking independence (LWI) 180 days after hip fracture surgery. Methods: This was a retrospective cohort study of patients aged 65 years and older who sustained a hip fracture and underwent surgery at a tertiary referral hospital between January 2021 and December 2023. The exposure was the GNRI, calculated based on admission blood test results using the following formula: 1.489 × serum albumin concentration [g/L] + 41.7 × (actual bodyweight / ideal bodyweight). LWI was defined as a Functional Independence Measure–Locomotion score ≤ 5 at telephone follow-up. Restricted cubic spline (RCS) was used to assess the shape of the association. Multivariable logistic regression estimated the odds ratio (OR) for LWI per 10-point decrease in GNRI. Robustness was evaluated using multiple sensitivity and prespecified subgroup analyses. Results: The cohort consisted of 1,345 patients (925 female [68.8%]; median [Q1-Q3] age, 76 [69–82] years), with 622 patients with LWI (46.2%) by 180 days. RCS analysis showed that lower GNRI values were linearly associated with higher odds of LWI (P for overall association = 0.003; P for nonlinearity = 0.326). After adjustment, each 10-point decrease in GNRI was associated with higher odds of LWI (adjusted OR, 1.30; 95% confidence interval, 1.13–1.52; P < 0.001). Results were generally consistent across sensitivity and subgroup analyses, with no significant heterogeneity after correction for multiple testing. Conclusion: Lower preoperative GNRI was associated with higher odds of LWI 180 days after hip fracture surgery. GNRI may be considered as one component of a comprehensive preoperative assessment, but should not be used as a stand-alone prognostic tool. The trial registration number (TRN): ChiCTR-PPC-14005360.
- 2 September 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
Open AccessAssociation between the preoperative geriatric nutritional risk index and loss of walking independence 180 days after hip fracture surgery: A retrospective cohort study
Background: Malnutrition may impair recovery after hip fracture, but the association between preoperative geriatric nutritional risk index (GNRI) and postoperative walking outcomes remains unclear. We examined the association between GNRI and loss of walking independence (LWI) 180 days after hip fracture surgery. Methods: This was a retrospective cohort study of patients aged 65 years and older who sustained a hip fracture and underwent surgery at a tertiary referral hospital between January 2021 and December 2023. The exposure was the GNRI, calculated based on admission blood test results using the following formula: 1.489 × serum albumin concentration [g/L] + 41.7 × (actual bodyweight / ideal bodyweight). LWI was defined as a Functional Independence Measure–Locomotion score ≤ 5 at telephone follow-up. Restricted cubic spline (RCS) was used to assess the shape of the association. Multivariable logistic regression estimated the odds ratio (OR) for LWI per 10-point decrease in GNRI. Robustness was evaluated using multiple sensitivity and prespecified subgroup analyses. Results: The cohort consisted of 1,345 patients (925 female [68.8%]; median [Q1-Q3] age, 76 [69–82] years), with 622 patients with LWI (46.2%) by 180 days. RCS analysis showed that lower GNRI values were linearly associated with higher odds of LWI (P for overall association = 0.003; P for nonlinearity = 0.326). After adjustment, each 10-point decrease in GNRI was associated with higher odds of LWI (adjusted OR, 1.30; 95% confidence interval, 1.13–1.52; P < 0.001). Results were generally consistent across sensitivity and subgroup analyses, with no significant heterogeneity after correction for multiple testing. Conclusion: Lower preoperative GNRI was associated with higher odds of LWI 180 days after hip fracture surgery. GNRI may be considered as one component of a comprehensive preoperative assessment, but should not be used as a stand-alone prognostic tool. The trial registration number (TRN): ChiCTR-PPC-14005360.
- Open Access
- 31 July 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Post-injury high-sensitivity C-reactive protein to lymphocyte ratio and nonunion risk in adult extremity fractures: evidence from a multicenter retrospective cohort
- 31 July 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Open AccessPost-injury high-sensitivity C-reactive protein to lymphocyte ratio and nonunion risk in adult extremity fractures: evidence from a multicenter retrospective cohort
- Open Access
- 24 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1747481
Association between triglyceride glucose–body mass index and nonunion in older patients following limb fracture surgery: a multicenter retrospective cohort study
Introduction: Metabolic syndrome (MetS) is increasingly recognized as an emerging risk factor affecting fracture healing. We sought to investigate the association between the metabolic abnormality indicator triglyceride glucose–body mass index (TyG–BMI) and postoperative nonunion in older patients with limb fractures. Methods: In a multicenter retrospective cohort study across five tertiary hospitals, we included older patients (≥60 years) undergoing limb fracture surgery between January 2020 and December 2022. The exposure of interest was the post-injury TyG–BMI, derived from fasting plasma glucose, triglyceride levels, and body mass index. The outcome was nonunion, defined as persistence of the fracture for 9 months or longer without evidence of healing for 3 months. Restricted cubic spline (RCS) model and multivariable logistic regression were used to evaluate the association between TyG–BMI and nonunion. Sensitivity analyses and subgroup analyses were conducted to evaluate the robustness and population heterogeneity of the primary outcome. Results: Among 8,499 eligible patients [median age 75.0 (67.0, 83.0) years; 60.5% male], 141 cases (1.66%) developed nonunion. RCS revealed a U-shaped, nonlinear relationship between TyG-BMI and nonunion, with risk-protective thresholds at 173.9 and 213.0. Compared with the reference range, both low (213.0) TyG-BMI levels were independently associated with increased risk [TyG-BMI < 173.9: adjusted relative risk (aOR), 1.358; 95% confidence interval (CI), 1.016–1.816; TyG–BMI > 213.0: aOR, 1.233; 95%CI, 1.030–1.475], which remained robust across multiple sensitivity and exploratory analyses. Significant interactions were observed between TyG-BMI levels and perioperative blood transfusion and bone grafting type (P for interaction < 0.05). Conclusion: Both low and high TyG-BMI levels are significantly associated with increased nonunion risk in older patients following limb fracture surgery, serving as a potential biomarker for risk stratification and individualized management.
- 24 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1747481
Open AccessAssociation between triglyceride glucose–body mass index and nonunion in older patients following limb fracture surgery: a multicenter retrospective cohort study
Introduction: Metabolic syndrome (MetS) is increasingly recognized as an emerging risk factor affecting fracture healing. We sought to investigate the association between the metabolic abnormality indicator triglyceride glucose–body mass index (TyG–BMI) and postoperative nonunion in older patients with limb fractures. Methods: In a multicenter retrospective cohort study across five tertiary hospitals, we included older patients (≥60 years) undergoing limb fracture surgery between January 2020 and December 2022. The exposure of interest was the post-injury TyG–BMI, derived from fasting plasma glucose, triglyceride levels, and body mass index. The outcome was nonunion, defined as persistence of the fracture for 9 months or longer without evidence of healing for 3 months. Restricted cubic spline (RCS) model and multivariable logistic regression were used to evaluate the association between TyG–BMI and nonunion. Sensitivity analyses and subgroup analyses were conducted to evaluate the robustness and population heterogeneity of the primary outcome. Results: Among 8,499 eligible patients [median age 75.0 (67.0, 83.0) years; 60.5% male], 141 cases (1.66%) developed nonunion. RCS revealed a U-shaped, nonlinear relationship between TyG-BMI and nonunion, with risk-protective thresholds at 173.9 and 213.0. Compared with the reference range, both low (213.0) TyG-BMI levels were independently associated with increased risk [TyG-BMI < 173.9: adjusted relative risk (aOR), 1.358; 95% confidence interval (CI), 1.016–1.816; TyG–BMI > 213.0: aOR, 1.233; 95%CI, 1.030–1.475], which remained robust across multiple sensitivity and exploratory analyses. Significant interactions were observed between TyG-BMI levels and perioperative blood transfusion and bone grafting type (P for interaction < 0.05). Conclusion: Both low and high TyG-BMI levels are significantly associated with increased nonunion risk in older patients following limb fracture surgery, serving as a potential biomarker for risk stratification and individualized management.
- Open Access
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13, rbag080
Piezo1-activated mesenchymal stem cells-derived extracellular matrix hydrogel promotes the repair of osteoporotic bone defects through osteogenic and angiogenic coupling
Osteoporotic bone defects present a significant clinical challenge due to impaired osteogenesis and angiogenesis, often leading to poor healing and bone regeneration. Current therapeutic approaches, including demineralized cancellous bone matrix and synthetic bioactive materials, are often limited by issues such as inadequate donor sources and immune responses. In this study, we developed a novel extracellular matrix hydrogel by optimizing extracellular matrix (ECM) derived from mesenchymal stem cells through preconditioning with Yoda1 (Y-ECM-gel), the Piezo1 mechanosensory channel agonist. The Y-ECM-gel retains the diversity of bioactive factors and structural features found in natural ECM while exhibiting remarkable physical stability. Our in vitro experiments demonstrated that Y-ECM-gel significantly promoted the proliferation, migration and osteogenic differentiation of mouse preosteoblast cells (MC3T3-E1), enhancing osteogenesis via activation of the PI3K/AKT signaling pathway. Additionally, Y-ECM-gel promoted the proliferation, migration and angiogenesis of human umbilical vein endothelial cells (HUVECs). In vivo experiments, it significantly stimulated bone tissue formation and neovascularization in the osteoporotic bone defect model. These findings indicate that Y-ECM-gel can restore bone homeostasis by promoting osteogenic-angiogenic coupling, providing a promising, minimally invasive and highly effective therapeutic strategy for bone regeneration in osteoporotic conditions.
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13, rbag080
Open AccessPiezo1-activated mesenchymal stem cells-derived extracellular matrix hydrogel promotes the repair of osteoporotic bone defects through osteogenic and angiogenic coupling
Osteoporotic bone defects present a significant clinical challenge due to impaired osteogenesis and angiogenesis, often leading to poor healing and bone regeneration. Current therapeutic approaches, including demineralized cancellous bone matrix and synthetic bioactive materials, are often limited by issues such as inadequate donor sources and immune responses. In this study, we developed a novel extracellular matrix hydrogel by optimizing extracellular matrix (ECM) derived from mesenchymal stem cells through preconditioning with Yoda1 (Y-ECM-gel), the Piezo1 mechanosensory channel agonist. The Y-ECM-gel retains the diversity of bioactive factors and structural features found in natural ECM while exhibiting remarkable physical stability. Our in vitro experiments demonstrated that Y-ECM-gel significantly promoted the proliferation, migration and osteogenic differentiation of mouse preosteoblast cells (MC3T3-E1), enhancing osteogenesis via activation of the PI3K/AKT signaling pathway. Additionally, Y-ECM-gel promoted the proliferation, migration and angiogenesis of human umbilical vein endothelial cells (HUVECs). In vivo experiments, it significantly stimulated bone tissue formation and neovascularization in the osteoporotic bone defect model. These findings indicate that Y-ECM-gel can restore bone homeostasis by promoting osteogenic-angiogenic coupling, providing a promising, minimally invasive and highly effective therapeutic strategy for bone regeneration in osteoporotic conditions.
- Top Cited PapersOpen Access
- 1 January 2026
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 22 (1) , 308-326
Piezo1-driven mechanotransduction regulates mitochondrial biogenesis by AMPK/SIRT1-mediated PGC-1α deacetylation to ameliorate bone loss in disuse osteoporosis
Disuse osteoporosis (DOP), a skeletal disorder triggered by insufficient mechanical loading, manifests as progressive bone mass deterioration and microarchitectural weakening. Piezo1, a key mechanosensitive ion channel expressed in bone cells, is implicated in maintaining skeletal homeostasis. Using a murine hindlimb unloading (HLU) model simulating microgravity-induced bone loss, we observed significant downregulation of Piezo1 expression in bone tissue and isolated bone marrow-derived mesenchymal stem cells (BMSCs). Systemic administration of the Piezo1 agonist Yoda1 attenuated HLU-induced osteopenia and improved bone formation capacity. Mechanistic studies in BMSCs demonstrated that Piezo1 activation promoted mitochondrial biogenesis. This effect required AMPK/SIRT1 signaling-dependent deacetylation of PGC-1α, leading to enhanced mitochondrial function, improved osteogenic differentiation, and reduced apoptosis. Critically, pharmacologic inhibition of SIRT1 abolished the osteoprotective effects of Yoda1 in vivo. These findings establish that mechanical unloading impairs Piezo1-mediated mechanotransduction in BMSCs, contributing to disrupted skeletal homeostasis, which can be mitigated by exogenous Piezo1 activation. Our results define a mechanism where Piezo1 integrates mechanical signals into the AMPK/SIRT1/PGC-1α signaling cascade to regulate mechanoadaptive bone formation, highlighting Piezo1 activation as a potential mechanism-based therapeutic strategy for disuse osteoporosis.
- 1 January 2026
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 22 (1) , 308-326
Top Cited PapersOpen AccessPiezo1-driven mechanotransduction regulates mitochondrial biogenesis by AMPK/SIRT1-mediated PGC-1α deacetylation to ameliorate bone loss in disuse osteoporosis
Disuse osteoporosis (DOP), a skeletal disorder triggered by insufficient mechanical loading, manifests as progressive bone mass deterioration and microarchitectural weakening. Piezo1, a key mechanosensitive ion channel expressed in bone cells, is implicated in maintaining skeletal homeostasis. Using a murine hindlimb unloading (HLU) model simulating microgravity-induced bone loss, we observed significant downregulation of Piezo1 expression in bone tissue and isolated bone marrow-derived mesenchymal stem cells (BMSCs). Systemic administration of the Piezo1 agonist Yoda1 attenuated HLU-induced osteopenia and improved bone formation capacity. Mechanistic studies in BMSCs demonstrated that Piezo1 activation promoted mitochondrial biogenesis. This effect required AMPK/SIRT1 signaling-dependent deacetylation of PGC-1α, leading to enhanced mitochondrial function, improved osteogenic differentiation, and reduced apoptosis. Critically, pharmacologic inhibition of SIRT1 abolished the osteoprotective effects of Yoda1 in vivo. These findings establish that mechanical unloading impairs Piezo1-mediated mechanotransduction in BMSCs, contributing to disrupted skeletal homeostasis, which can be mitigated by exogenous Piezo1 activation. Our results define a mechanism where Piezo1 integrates mechanical signals into the AMPK/SIRT1/PGC-1α signaling cascade to regulate mechanoadaptive bone formation, highlighting Piezo1 activation as a potential mechanism-based therapeutic strategy for disuse osteoporosis.
- Open Access
- 4 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1714912
Effectiveness of physical therapies for patients with knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials
Background: Physical therapy offers a useful option for management of knee osteoarthritis (KOA) and this study aims to summarize the latest evidence on the effectiveness of variable physical therapies. Methods: We considered randomized trials of patients with KOA that compared any of the following interventions for treatment of osteoarthritis pain: physical therapies, general nursing, placebo. We performed frequentist random-effect network meta-analyses to summarize the evidence and applied the Confidence in Network Meta-Analysis frameworks to rate the certainty of evidence, calculate the treatment effects, categorize interventions, and present the findings. Results: The search identified 74 eligible RCTs, enrolling 3,707 participants. TENS demonstrated the largest reduction of NRS (MD, −2.73; 95% CI, −5.20 to −0.26) and VAS pain at rest (MD, −2.87; 95% CI, −4.87 to −0.87). Moderate to low-level evidence established laser as most effective for improving VAS for pain during walking at <1 month (MD, −2.50; 95% CI, −3.88 to −1.11) and 1–3 months (MD, −2.49; 95% CI, −4.51 to −0.48), and neuromuscular exercise (MD, −1.77; 95% CI, −3.14 to −0.39) at 3 months. For WOMAC total scores at 3 months, shockwave (MD, −9.56; 95% CI, −16.71 to −2.41; low-level confidence), aquatic sports (MD, −16.53; 95% CI, −30.74 to −2.31; low-level confidence), and shockwave (MD, −30.02; 95% CI, −40.39 to −19.65, moderate-level confidence) respectively, demonstrated the greatest improvements. Conclusion: Physical therapies exhibited varying efficacy profiles in management of KOA with most being supported by moderate-to-low levels evidence, warranting further studies to better establish their effectiveness. Systematic review registration: Identifier PROSPERO CRD42023458296.
- 4 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1714912
Open AccessEffectiveness of physical therapies for patients with knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials
Background: Physical therapy offers a useful option for management of knee osteoarthritis (KOA) and this study aims to summarize the latest evidence on the effectiveness of variable physical therapies. Methods: We considered randomized trials of patients with KOA that compared any of the following interventions for treatment of osteoarthritis pain: physical therapies, general nursing, placebo. We performed frequentist random-effect network meta-analyses to summarize the evidence and applied the Confidence in Network Meta-Analysis frameworks to rate the certainty of evidence, calculate the treatment effects, categorize interventions, and present the findings. Results: The search identified 74 eligible RCTs, enrolling 3,707 participants. TENS demonstrated the largest reduction of NRS (MD, −2.73; 95% CI, −5.20 to −0.26) and VAS pain at rest (MD, −2.87; 95% CI, −4.87 to −0.87). Moderate to low-level evidence established laser as most effective for improving VAS for pain during walking at <1 month (MD, −2.50; 95% CI, −3.88 to −1.11) and 1–3 months (MD, −2.49; 95% CI, −4.51 to −0.48), and neuromuscular exercise (MD, −1.77; 95% CI, −3.14 to −0.39) at 3 months. For WOMAC total scores at 3 months, shockwave (MD, −9.56; 95% CI, −16.71 to −2.41; low-level confidence), aquatic sports (MD, −16.53; 95% CI, −30.74 to −2.31; low-level confidence), and shockwave (MD, −30.02; 95% CI, −40.39 to −19.65, moderate-level confidence) respectively, demonstrated the greatest improvements. Conclusion: Physical therapies exhibited varying efficacy profiles in management of KOA with most being supported by moderate-to-low levels evidence, warranting further studies to better establish their effectiveness. Systematic review registration: Identifier PROSPERO CRD42023458296.
- Open Access
- 18 November 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102559
Mild photothermal-mediated neuroimmunomodulatory composite hydrogel ameliorates bone healing microenvironment for enhanced osteoporotic bone defect regeneration
- 18 November 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102559
Open AccessMild photothermal-mediated neuroimmunomodulatory composite hydrogel ameliorates bone healing microenvironment for enhanced osteoporotic bone defect regeneration